INGERSOLL RAND INC

Company Overview

Ingersoll Rand (sector: Industrials; industry: Specialty Industrial Machinery) is a diversified global manufacturer of compressors, pumps, vacuum pumps, blowers, fluid-transfer equipment and life-science tools sold under 80+ brands into end markets such as life sciences, food & beverage, clean energy and general manufacturing. The business is split into Industrial Technologies & Services and Precision & Science Technologies, with a large installed base driving recurring aftermarket revenue (36.4% of 2024 revenue) and a global footprint of ~60 manufacturing sites and 40+ service centers. Management has leaned on M&A (notably ILC Dover) and pricing to drive revenue and margin expansion, funded with substantial long‑term debt (~$4.7B) and supported by robust adjusted EBITDA and FCF, while recent quarters showed goodwill/intangible impairments and softer organic equipment demand. Key operational exposures include commodity inputs, some single‑source castings/motors, foreign‑currency mix (50%+ non‑USD revenues) and environmental/regulatory risks tied to manufacturing and life‑science products.

Executive Compensation Practices

Given the business model and management disclosures, incentive pay is likely tied heavily to non‑GAAP financial metrics the company emphasizes—Adjusted EBITDA, Adjusted EBITDA margin, gross margin expansion, free cash flow and working‑capital improvement—plus targets for organic revenue growth and aftermarket recurring revenue mix. Because M&A has been a central driver of recent growth, long‑term awards and retention incentives are likely structured to reward successful integration (post‑acquisition revenue/EBITDA targets), and equity‑based pay (PSUs/RSUs) will often be linked to multi‑year ROIC/TSR and leverage reduction goals. For the Precision & Science Technologies segment, compensation may include product‑specific KPIs such as consumables/recurring revenue growth, regulatory milestones and time‑to‑market for single‑use assemblies. The use of non‑GAAP measures and material accounting judgments (goodwill/intangible impairment tests, business combination allocations) means pay outcomes can be sensitive to one‑time accounting items and management discretion, so clawbacks, performance gates and multi‑year performance periods are typical mitigants.

Insider Trading Considerations

Insiders at IR will commonly trade around clear information events: quarterly results (especially given recent goodwill/intangible impairments), major M&A announcements/financing transactions, and material regulatory or product milestones in the life‑science segment. Expect routine use of 10b5‑1 plans and standard blackout windows around earnings and deal negotiations; however, high leverage, active M&A, and impairment risk increase the likelihood that option exercises and subsequent sales occur when insiders diversify or meet tax obligations after vesting events. Cross‑border operations and material non‑USD exposure mean FX and country‑specific developments can be material; watch insider activity around news of supply‑chain disruptions (single‑source castings/motors), debt financing/refinancings, or changes in environmental/regulatory remediation obligations. For traders and researchers, spikes in insider buying after impairment-driven lows or insider sales timed just before large M&A or debt raises can be informative signals about management conviction or liquidity needs.